Press release
Key Trends Reshaping the Hypoparathyroidism Market: Transcon Platform Enables Long-Acting Prodrugs For Sustained Hormone Release Industry Transformation
Hypoparathyroidism
Hypoparathyroidism Market Size Growth Forecast: What to Expect by 2025?
In recent times, the hypoparathyroidism market has experienced robust growth. The market size, which stands at $0.95 billion in 2024, is projected to expand to $1.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. This historical growth is due to factors such as the growing number of thyroid surgeries, increased awareness about hypoparathyroidism, a surge in post-operative complications, a rise in the demand for calcium and vitamin D supplements, and an enhanced focus on the management of endocrine disorders.
How Will the Hypoparathyroidism Market Size Evolve and Grow by 2029?
The market for hypoparathyroidism is predicted to experience substantial growth in the upcoming years, with expectations of reaching $1.42 billion in 2029, indicating a compound annual growth rate (CAGR) of 8.3%. This projected growth during the forecast period can be traced back to the increasing incorporation of recombinant parathyroid hormone therapies, escalating investment in hypoparathyroidism research, expansion of the healthcare sector, a growing elderly demographic susceptible to endocrine disorders, and rising awareness leading to early diagnosis. The forecast period is also expected to witness advancements in parathyroid hormone therapies, enhanced diagnostic procedures for hypoparathyroidism, emergence of sustained-release calcium supplements, innovations in minimally invasive thyroid surgery, and further advancements in patient monitoring technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hypoparathyroidism-global-market-report
What Drivers Are Propelling the Growth of Hypoparathyroidism Market Forward?
Rising cases of thyroid cancer are anticipated to fuel the expansion of the hypoparathyroidism market in the future. Thyroid cancer involves the abnormal growth of cells in the thyroid gland, often appearing as a lump in the neck. Improved diagnostic imaging technologies have led to increasing instances of thyroid cancer, as these technologies facilitate early and more regular detection of small, symptomless thyroid nodules. Hypoparathyroidism is indirectly prompted by thyroid cancer due to the increased need for thyroid surgeries, which can unintentionally harm the parathyroid glands. This results in calcium imbalance and persistent hormone deficiency, thereby increasing the need for enduring disease management solutions. For example, the American Cancer Society, a not-for-profit organization based in the US, reported in May 2024 that the number of new thyroid cancer cases surged to 44,020 in 2025 from 43,720 in 2023. Consequently, the escalating instances of thyroid cancer are spurring the growth of the hypoparathyroidism market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24565&type=smp
Which Emerging Trends Are Transforming the Hypoparathyroidism Market in 2025?
Leading companies in the hypoparathyroidism market are striving to create more technologically sophisticated products, such as those based on transition technology, to boost treatment effectiveness and better patient outcomes. These transition technology-based products are therapeutics created with TransCon (Transient Conjugation) technology, an exclusive platform aimed at enhancing drug delivery capabilities. For example, in January 2024, Ascendis Pharma A/S, a biopharmaceutical enterprise based in Denmark, introduced YORVIPATH (palopegteriparatide), its second product using TransCon technology, in Germany and Austria to treat adults suffering from chronic hypoparathyroidism. YORVIPATH is a once-a-day prodrug of parathyroid hormone (PTH 1-34) which aims to sustain physiological PTH levels throughout a 24-hour period, targeting the foundational hormone deficiency found in chronic hypoparathyroidism.
What Are the Key Segments in the Hypoparathyroidism Market?
The hypoparathyroidism market covered in this report is segmented -
1) By Treatment: Hormone Replacement Therapy, Adjunctive Therapies
2) By Type: Hormone Replacement Therapy, Calcium And Vitamin D Supplements, Emerging Therapies
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospitals, Specialty Clinics, Homecare Settings
Subsegments:
1) By Hormone Replacement Therapy: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues, Calcimimetics, Calcium And Vitamin D Supplements
2) By Adjunctive Therapies: Magnesium Supplements, Phosphate Binders, Other Supportive Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24565&type=smp
Who Are the Key Players Shaping the Hypoparathyroidism Market's Competitive Landscape?
Major companies operating in the hypoparathyroidism market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc , Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited , Lupin Limited, Torrent Pharmaceuticals Ltd., Eagle Pharmaceuticals Inc., BridgeBio Pharma Inc., Ascendis Pharma A/S, Extend Biosciences Inc., Entera Bio Ltd.
What Geographic Markets Are Powering Growth in the Hypoparathyroidism Market?
North America was the largest region in the hypoparathyroidism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hypoparathyroidism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24565
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trends Reshaping the Hypoparathyroidism Market: Transcon Platform Enables Long-Acting Prodrugs For Sustained Hormone Release Industry Transformation here
News-ID: 4092772 • Views: …
More Releases from The Business Research Company
Leading Companies Advancing Innovation and Growth in the Outboard Engines Market
The outboard engines market is positioned for significant growth in the coming years, driven by advancements in technology and changing consumer preferences. The evolving landscape highlights key innovations and strategic moves by industry leaders to capitalize on emerging opportunities. Let's explore the market size projections, leading companies, future trends, and segmentation details shaping this industry.
Expected Expansion of the Outboard Engines Market by 2030
The outboard engines market is projected…
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the …
The off-road vehicle market is steadily gaining traction as demand rises across multiple sectors. Innovations in technology, growing interest in outdoor adventure, and strategic defense initiatives are all contributing to a promising outlook for this dynamic industry. Let's explore the market's size, key players, emerging trends, and segmentation to better understand what lies ahead.
Projected Expansion and Market Size of the Off-Road Vehicle Market
The off-road vehicle industry is set…
Leading Companies Enhancing Their Presence in the Mountain and Snow Tourism Mark …
The mountain and snow tourism sector is gaining considerable momentum as travelers seek unique and immersive outdoor experiences. With evolving preferences and technological advancements, this industry is set to grow significantly over the coming years. Let's explore the current market size, leading players, emerging trends, and key segments shaping this exciting travel niche.
Projected Market Size Growth in Mountain and Snow Tourism
The mountain and snow tourism market is poised…
Future Perspectives: Key Trends Shaping the Motor Vehicle Seating and Interior T …
The motor vehicle seating and interior trim sector is poised for impressive growth over the next several years. As automotive design evolves and consumer preferences shift, this market is expected to expand substantially, driven by several notable trends and innovations. Below, we explore the market's size, major players, key growth drivers, and segmentation details to provide a comprehensive view of what lies ahead.
Projected Expansion of the Motor Vehicle Seating and…
More Releases for Hypoparathyroidism
Hypoparathyroidism Market to Reach USD 2.06 Billion by 2034
Pune, India - December 2025 - The global Hypoparathyroidism Market, valued at USD 1.21 billion in 2024, is projected to reach USD 2.06 billion by 2034, growing at a 5.5% CAGR (2025-2034), according to Exactitude Consultancy. Increasing incidence of post-thyroidectomy hypoparathyroidism, improved diagnosis of chronic hypocalcemia, and expanding use of recombinant parathyroid hormone (PTH) therapies are key market growth drivers.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71995
Market Summary
The…
Hypoparathyroidism Market Size, Development, Key Opportunity, Application & Fore …
The global hypoparathyroidism market was valued at approximately $1.3 billion in 2023 and is projected to reach around $2.5 billion by 2031. This represents a compound annual growth rate (CAGR) of about 8.8%.
Request a Free Sample Copy@ https://www.datalibraryresearch.com/sample-request/hypoparathyroidism-market-5438
With market research reports garnering immense significance in the speedily transforming market place, the team at Data Library Research endows with Hypoparathyroidism Market report in a way which is predicted. It comprehensively…
Hypoparathyroidism Drug Market: An Overview
Hypoparathyroidism is a rare endocrine disorder characterized by insufficient production of parathyroid hormone (PTH), leading to low calcium levels in the blood. This deficiency causes various complications, including muscle cramps, fatigue, and neurological issues. Managing hypoparathyroidism primarily involves calcium and vitamin D supplements, but newer treatments targeting PTH replacement therapy have emerged, providing more effective and sustainable solutions.
The development of hypoparathyroidism drugs represents a promising area of growth in the…
Hypoparathyroidism Drug Market Size, Share, Trends, Growth and Competitive Analy …
Hypoparathyroidism Drug Market business report provides a profound overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. The data and information collected to generate this top-notch market report has been derived from the trusted sources such as company websites, white papers, journals, and mergers etc. Hypoparathyroidism Drug Market report includes basic, secondary and advanced information related to the global…
Hypoparathyroidism Treatment Market Size 2024 to 2031.
Market Overview and Report Coverage
Hypoparathyroidism is a rare condition where the parathyroid glands in the neck produce too little parathyroid hormone, resulting in low calcium levels in the blood. The primary treatment for hypoparathyroidism involves calcium and vitamin D supplementation, as well as hormonal therapy.
The future outlook for the Hypoparathyroidism Treatment Market is promising, with a projected growth rate of 20.00% during the forecasted period. This growth can…
Hypoparathyroidism Treatment Market Size, Share, Trends, Analysis and Forecast 2 …
The Global Hypoparathyroidism Treatment Market is poised to register a CAGR of over 8% during the forecast period 2020 to 2027.
Hypoparathyroidism occurs when the parathyroid glands does not produce enough hormone. Hyperparathyroidism can be caused by a number of factors, including injury or removal of the parathyroid glands, DiGeorge syndrome, an autoimmune disease, cancer radiation treatment, and low magnesium levels. The main function of parathyroid hormone is to regulate blood…
